Regarding the relationship between OD and AD biomarkers, a small meta-analysis on 9 studies including cognitively unimpaired (CU), MCI, and AD patients concluded that the association between odor identification and Aβ and tau burden was negligible [25]. Here, MAPT is linked to Alzheimer disease.